A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare ...

The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Revvity's Dharmacon All-in-one lentiviral platform has expanded to include whole-genome library options for CRISPR knockout (CRISPRko), CRISPR interference (CRISPRi), and CRISPR activation (CRISPRa).

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...